NRCME (DOT) CERTIFICATION EXAM ACTUAL 2026/2027 PRACTICE
QUESTIONS COMPLETE ACCURATE EXAM APPROVED QUESTIONS
AND CORRECT DETAILED SOLUTIONS WITH RATIONALES (RELIABLE
ANSWERS) LATEST UPDATED VERSION 2026 EDITION |GUARANTEED
SUCCESS A+ (BRAND NEW!) FULL REVISED NRCME (DOT) ACTUAL
CERTIFIACATION EXAM
1. A commercial driver presents for a biennial physical examination. Which of the
following is the minimum acceptable visual acuity required for certification, with
or without correction?
A) 20/40 in one eye and 20/100 in the other
B) 20/40 in each eye
C) 20/50 in the better eye and 20/100 in the other
D) 20/70 in both eyes combined
CORRECT ANSWER: B
Rationale: The Federal Motor Carrier Safety Administration (FMCSA) requires
that a commercial driver have distant visual acuity of at least 20/40 in each eye,
with or without corrective lenses. This ensures adequate binocular vision for safe
operation of a commercial motor vehicle. Options A, C, and D do not meet the
minimum standard for certification.
2. A driver has a history of insulin-treated diabetes mellitus. Under the current
FMCSA guidelines, which of the following is required for certification?
A) A waiver from the state licensing agency
B) An annual ophthalmologic examination
C) A Federal Diabetes Exemption or compliance with the insulin-treated diabetes
mellitus assessment protocol
D) Complete avoidance of commercial driving
,CORRECT ANSWER: C
Rationale: The FMCSA allows drivers with insulin-treated diabetes mellitus to
be certified if they meet specific requirements under the insulin-treated diabetes
mellitus assessment protocol or hold a Federal Diabetes Exemption. This
includes stable control, no severe hypoglycemic episodes, and regular
monitoring. Options A, B, and D are incorrect because they do not reflect the
current regulatory pathway.
3. During a physical examination, you note that a driver has a blood pressure of
148/92 mmHg. According to FMCSA guidelines, what is the appropriate
certification action?
A) Certify for 2 years with no restrictions
B) Certify for 1 year with a requirement for annual monitoring
C) Issue a 3-month temporary certificate and refer for evaluation
D) Deny certification immediately
CORRECT ANSWER: B
Rationale: A blood pressure of 148/92 mmHg falls into Stage 1 hypertension
(140-159/90-99). The FMCSA allows certification for up to 1 year, provided the
driver is monitored and treated. A 3-month certificate is for Stage 2 hypertension
(≥160/100), and immediate denial is not required at this level. Option A is
incorrect because 2-year certification requires blood pressure below 140/90.
4. Which of the following cardiovascular conditions would require a minimum 3-
month waiting period before certification can be considered?
A) Hypertension controlled with medication
B) Myocardial infarction within the past 6 months
C) Pacemaker implantation for bradycardia
D) Coronary artery bypass grafting with full recovery and no symptoms
,CORRECT ANSWER: B
Rationale: A myocardial infarction requires a waiting period of at least 3
months, and often up to 6 months, depending on the severity and recovery.
FMCSA guidelines recommend that drivers with a recent MI undergo evaluation
and stress testing before certification. Options A, C, and D may allow
certification sooner if stable and asymptomatic.
5. A driver reports a history of seizures but has been off antiseizure medication for
5 years without any recurrence. What is the most appropriate action?
A) Certify without restrictions
B) Require a neurological evaluation and then certify
C) Deny certification permanently
D) Issue a 1-year certificate with annual neurological reports
CORRECT ANSWER: B
. Rationale: A driver with a history of seizures may be certified if they have been
seizure-free for at least 10 years off medication, or 5 years on medication. Since
this driver is off medication for 5 years, a neurological evaluation is needed to
confirm stability. Option A is premature, C is too restrictive, and D is not
standard for this scenario
6. According to FMCSA standards, what is the maximum allowable blood alcohol
concentration (BAC) for a commercial driver while on duty?
A) 0.04%
B) 0.08%
C) 0.02%
D) 0.00%
, CORRECT ANSWER: A
Rationale: The FMCSA mandates that a commercial driver cannot have a BAC
of 0.04% or higher while operating a commercial motor vehicle. This is stricter
than the 0.08% limit for non-commercial drivers. Option D (0.00%) is not the
legal limit but is often recommended for safety.
7. A driver has a diagnosis of obstructive sleep apnea (OSA) but refuses to use a
CPAP machine. What is the correct certification decision?
A) Certify for 1 year with a warning
B) Certify for 3 months to allow compliance
C) Deny certification until treatment is initiated and effective
D) Certify with a restriction for daytime driving only
CORRECT ANSWER: C
Rationale: Untreated OSA poses a significant risk of excessive daytime
sleepiness and crashes. FMCSA guidelines require that drivers with OSA adhere
to treatment (e.g., CPAP). Refusal to use treatment is grounds for denial until
the driver demonstrates compliance and effectiveness. Options A, B, and D are
not appropriate because they do not address the safety risk.
8. Which of the following medications is prohibited for commercial drivers under
FMCSA regulations?
A) Metformin
B) Lisinopril
C) Amphetamine-based stimulants
D) Atorvastatin
CORRECT ANSWER: C
QUESTIONS COMPLETE ACCURATE EXAM APPROVED QUESTIONS
AND CORRECT DETAILED SOLUTIONS WITH RATIONALES (RELIABLE
ANSWERS) LATEST UPDATED VERSION 2026 EDITION |GUARANTEED
SUCCESS A+ (BRAND NEW!) FULL REVISED NRCME (DOT) ACTUAL
CERTIFIACATION EXAM
1. A commercial driver presents for a biennial physical examination. Which of the
following is the minimum acceptable visual acuity required for certification, with
or without correction?
A) 20/40 in one eye and 20/100 in the other
B) 20/40 in each eye
C) 20/50 in the better eye and 20/100 in the other
D) 20/70 in both eyes combined
CORRECT ANSWER: B
Rationale: The Federal Motor Carrier Safety Administration (FMCSA) requires
that a commercial driver have distant visual acuity of at least 20/40 in each eye,
with or without corrective lenses. This ensures adequate binocular vision for safe
operation of a commercial motor vehicle. Options A, C, and D do not meet the
minimum standard for certification.
2. A driver has a history of insulin-treated diabetes mellitus. Under the current
FMCSA guidelines, which of the following is required for certification?
A) A waiver from the state licensing agency
B) An annual ophthalmologic examination
C) A Federal Diabetes Exemption or compliance with the insulin-treated diabetes
mellitus assessment protocol
D) Complete avoidance of commercial driving
,CORRECT ANSWER: C
Rationale: The FMCSA allows drivers with insulin-treated diabetes mellitus to
be certified if they meet specific requirements under the insulin-treated diabetes
mellitus assessment protocol or hold a Federal Diabetes Exemption. This
includes stable control, no severe hypoglycemic episodes, and regular
monitoring. Options A, B, and D are incorrect because they do not reflect the
current regulatory pathway.
3. During a physical examination, you note that a driver has a blood pressure of
148/92 mmHg. According to FMCSA guidelines, what is the appropriate
certification action?
A) Certify for 2 years with no restrictions
B) Certify for 1 year with a requirement for annual monitoring
C) Issue a 3-month temporary certificate and refer for evaluation
D) Deny certification immediately
CORRECT ANSWER: B
Rationale: A blood pressure of 148/92 mmHg falls into Stage 1 hypertension
(140-159/90-99). The FMCSA allows certification for up to 1 year, provided the
driver is monitored and treated. A 3-month certificate is for Stage 2 hypertension
(≥160/100), and immediate denial is not required at this level. Option A is
incorrect because 2-year certification requires blood pressure below 140/90.
4. Which of the following cardiovascular conditions would require a minimum 3-
month waiting period before certification can be considered?
A) Hypertension controlled with medication
B) Myocardial infarction within the past 6 months
C) Pacemaker implantation for bradycardia
D) Coronary artery bypass grafting with full recovery and no symptoms
,CORRECT ANSWER: B
Rationale: A myocardial infarction requires a waiting period of at least 3
months, and often up to 6 months, depending on the severity and recovery.
FMCSA guidelines recommend that drivers with a recent MI undergo evaluation
and stress testing before certification. Options A, C, and D may allow
certification sooner if stable and asymptomatic.
5. A driver reports a history of seizures but has been off antiseizure medication for
5 years without any recurrence. What is the most appropriate action?
A) Certify without restrictions
B) Require a neurological evaluation and then certify
C) Deny certification permanently
D) Issue a 1-year certificate with annual neurological reports
CORRECT ANSWER: B
. Rationale: A driver with a history of seizures may be certified if they have been
seizure-free for at least 10 years off medication, or 5 years on medication. Since
this driver is off medication for 5 years, a neurological evaluation is needed to
confirm stability. Option A is premature, C is too restrictive, and D is not
standard for this scenario
6. According to FMCSA standards, what is the maximum allowable blood alcohol
concentration (BAC) for a commercial driver while on duty?
A) 0.04%
B) 0.08%
C) 0.02%
D) 0.00%
, CORRECT ANSWER: A
Rationale: The FMCSA mandates that a commercial driver cannot have a BAC
of 0.04% or higher while operating a commercial motor vehicle. This is stricter
than the 0.08% limit for non-commercial drivers. Option D (0.00%) is not the
legal limit but is often recommended for safety.
7. A driver has a diagnosis of obstructive sleep apnea (OSA) but refuses to use a
CPAP machine. What is the correct certification decision?
A) Certify for 1 year with a warning
B) Certify for 3 months to allow compliance
C) Deny certification until treatment is initiated and effective
D) Certify with a restriction for daytime driving only
CORRECT ANSWER: C
Rationale: Untreated OSA poses a significant risk of excessive daytime
sleepiness and crashes. FMCSA guidelines require that drivers with OSA adhere
to treatment (e.g., CPAP). Refusal to use treatment is grounds for denial until
the driver demonstrates compliance and effectiveness. Options A, B, and D are
not appropriate because they do not address the safety risk.
8. Which of the following medications is prohibited for commercial drivers under
FMCSA regulations?
A) Metformin
B) Lisinopril
C) Amphetamine-based stimulants
D) Atorvastatin
CORRECT ANSWER: C
